JP2010528644A5 - - Google Patents

Download PDF

Info

Publication number
JP2010528644A5
JP2010528644A5 JP2010510871A JP2010510871A JP2010528644A5 JP 2010528644 A5 JP2010528644 A5 JP 2010528644A5 JP 2010510871 A JP2010510871 A JP 2010510871A JP 2010510871 A JP2010510871 A JP 2010510871A JP 2010528644 A5 JP2010528644 A5 JP 2010528644A5
Authority
JP
Japan
Prior art keywords
human
tissue
dna sequence
cell according
human animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010510871A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010528644A (ja
Filing date
Publication date
Priority claimed from US11/757,972 external-priority patent/US7759541B2/en
Application filed filed Critical
Publication of JP2010528644A publication Critical patent/JP2010528644A/ja
Publication of JP2010528644A5 publication Critical patent/JP2010528644A5/ja
Pending legal-status Critical Current

Links

JP2010510871A 2007-06-04 2008-06-04 薬物の代謝及び毒性を評価するためのトランスジェニック動物 Pending JP2010528644A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/757,972 US7759541B2 (en) 2004-12-13 2007-06-04 Transgenic animals for assessing drug metabolism and toxicity
PCT/GB2008/001897 WO2008149080A1 (en) 2007-06-04 2008-06-04 Transgenic animals for assessing drug metabolism and toxicity

Publications (2)

Publication Number Publication Date
JP2010528644A JP2010528644A (ja) 2010-08-26
JP2010528644A5 true JP2010528644A5 (enExample) 2011-07-14

Family

ID=39698732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010510871A Pending JP2010528644A (ja) 2007-06-04 2008-06-04 薬物の代謝及び毒性を評価するためのトランスジェニック動物

Country Status (8)

Country Link
US (3) US7759541B2 (enExample)
EP (1) EP2173160A1 (enExample)
JP (1) JP2010528644A (enExample)
AU (1) AU2008259618A1 (enExample)
CA (1) CA2688438A1 (enExample)
IL (1) IL202127A0 (enExample)
IN (1) IN2009DN07390A (enExample)
WO (1) WO2008149080A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
EP2218786B1 (en) * 2007-11-14 2013-09-18 National University Corporation Tottori University Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster), and non-human mammalian animal retaining the same
EP3417701B1 (en) 2009-10-06 2021-12-15 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
CN102286398B (zh) * 2010-06-21 2014-06-04 中国科学院上海生命科学研究院 一种生产高活性和高纯度利福霉素sv的方法
US20120023599A1 (en) * 2010-07-23 2012-01-26 Sigma-Aldrich Co. Genome editing of cytochrome p450 in animals
RU2577978C2 (ru) 2011-02-15 2016-03-20 Ридженерон Фармасьютикалз, Инк. Гуманизированные m-csf мыши
FR2979453B1 (fr) * 2011-08-26 2016-01-08 Olea Medical Systeme et procede pour estimer une quantite d'interet d'un systeme dynamique artere/tissu/veine
RU2751240C2 (ru) * 2011-10-28 2021-07-12 Регенерон Фармасьютикалс, Инк. Гуманизированные il-6 и рецептор il-6
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
NZ746089A (en) 2012-09-07 2020-05-29 Institute For Res In Biomedicine Irb Genetically modified non-human animals and methods of use thereof
ES2748662T3 (es) 2012-11-05 2020-03-17 Institute For Res In Biomedicine Irb Roedores inmunodeficientes modificados genéticamente y métodos de uso de los mismos
US20140273031A1 (en) * 2013-03-15 2014-09-18 The Cleveland Clinic Foundation In-vitro method for monoclonal antibody production
TR201904342T4 (tr) 2013-10-15 2019-05-21 Regeneron Pharma Hümani̇ze il-15 hayvanlar
EP3430898A1 (en) * 2013-11-19 2019-01-23 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
EP3071024B1 (en) * 2013-11-19 2018-09-05 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
US9665718B2 (en) 2014-03-14 2017-05-30 International Business Machines Corporation Correlating a task with commands to perform a change ticket in an IT system
KR102821645B1 (ko) 2014-05-19 2025-06-19 리제너론 파마슈티칼스 인코포레이티드 인간 epo를 발현하는 유전자 변형된 비-인간 동물
SG10202103445QA (en) 2015-04-13 2021-05-28 Regeneron Pharma Humanized sirpa-il15 knockin mice and methods of use thereof
JP2019524077A (ja) 2016-06-27 2019-09-05 ベイラー カレッジ オブ メディスンBaylor College Of Medicine P450オキシドレダクターゼ欠損を有するヒト肝臓キメラ非ヒト動物およびそれを使用する方法
CN109182292B (zh) * 2018-09-25 2022-02-08 安徽农业大学 一种草莓谷胱甘肽转移酶FaGST基因及其表达蛋白和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206906A4 (en) 1999-08-13 2004-12-29 Kirin Brewery MOUSE CONTAINING A HUMAN P450 CYTOCHROME
EP1088900A1 (en) 1999-09-10 2001-04-04 Epidauros Biotechnologie AG Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications
CA2426959C (en) 2000-11-01 2011-10-04 The University Of Sydney Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
JP2003304896A (ja) 2002-04-15 2003-10-28 Yasushi Yamazoe ヒトcyp3a誘導能の測定法
GB0216203D0 (en) 2002-07-12 2002-08-21 Imp Cancer Res Tech Mondulation of cytochrome P450 reductase activity
AU2003278790A1 (en) * 2002-09-09 2004-03-29 California Institute Of Technology Methods and compositions for the generation of humanized mice
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
AU2005315438B2 (en) 2004-12-13 2012-02-23 Iti Scotland Limited Transgenic animals for assessing drug metabolism and toxicity

Similar Documents

Publication Publication Date Title
JP2010528644A5 (enExample)
MacKenzie et al. Regulation of UDP glucuronosyltransferase genes
Brady et al. A Novel Putative Transporter Maps to the Osteosclerosis (oc) Mutation and Is Not Expressed in theocMutant Mouse
JP2011501652A5 (enExample)
Scheer et al. Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications
JP2015523863A5 (enExample)
JP7702140B2 (ja) P450オキシドレダクターゼ欠損を有するヒト肝臓キメラ非ヒト動物およびそれを使用する方法
ES2384760T3 (es) Deleción de un grupo de genes y humanización en dos etapas
CN107815468A (zh) 人源化基因改造动物模型的制备方法及应用
WO2014028509A2 (en) Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
Tchekneva et al. Single amino acid substitution in aquaporin 11 causes renal failure
Kamimura Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations
ZA200606461B (en) Gene disruptions, compositions and methods relating thereto
Shen et al. Humanized transgenic mouse models for drug metabolism and pharmacokinetic research
WO2009050484A1 (en) Knockout mice for a p450 gene cluster
Katoh et al. Comparative integromics on FZD7 orthologs: conserved binding sites for PU. 1, SP1, CCAAT-box and TCF/LEF/SOX transcription factors within 5'-promoter region of mammalian FZD7 orthologs
Katoh et al. Conserved POU/OCT-and GATA-binding sites in 5'-flanking promoter region of mammalian WNT8B orthologs
KR101720099B1 (ko) 당뇨병 동물 모델 및 그 제조방법
Zhou et al. CYP2D1 gene knockout reduces the metabolism and efficacy of venlafaxine in rats
Yasui et al. Molecular characterization of striated muscle-specific Gab1 isoform as a critical signal transducer for neuregulin-1/ErbB signaling in cardiomyocytes
Uno et al. CYP2G2, pseudogenized in human, is expressed in nasal mucosa of cynomolgus monkey and encodes a functional drug-metabolizing enzyme
NZ765428B2 (en) Non-human animals having a humanized programmed cell death 1 gene
王惠亮 et al. Molecular cloning and sequencing of heavy and light chain cDNAs from Papaya ringspot and Cymbidium mosaic viruses-specific monoclonal antibodies
CN101060855A (zh) 胃肠增殖因子及其用途
Perez Factores estructurales que regulan la actividad de la metionina adenosiltransferasa hepatica